Radical prostatectomy versus watchful waiting in early prostate cancer.

By P. Walsh. Journal of Urology, 2005

1,192 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/7887a3099923540f04b42cdea0e6cfb129a8e6cd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Pulmonary and Respiratory Medicine

Citations in the corpus

Early Detection of Prostate Cancer: AUA Guideline (2013, background): “Although men in this age group have a higher prevalence of prostate cancer and a higher incidence of fatal tumors, they also have increased competing mortality compared to younger men(22) and no compelling evidence of a treatment benefit, especially in men with a limited life expectancy below 10 to ”
Prostate Cancer (2018, background): “The study with the longest follow-up period [13] showed a significant advantage of overall survival for radical prostatectomy, however, only in patients < 65 years.”
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. (2012, background): “These differences are potentially important given a recent report that radical prostatectomy is associated with improved mortality in young men with aggressive cancers (13).”
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options (2017, methodology): “6% at fifteen years.(23) PIVOT is the only randomized controlled trial to have included pre-specified analyses for evaluating survival differences stratified by prostate cancer risk categories and by PSA at initial diagnosis.”
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring (2008, background): “In the Scandinavian trial of radical prostatectomy versus watchful waitin”
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort (2007, background): “4 demonstrated that surgery significantly decreased the risk of death from prostate cancer (Holmberg et al., 2002; Bill-Axelson et al., 2005).”
Guideline for the management of clinically localized prostate cancer: 2007 update. (2007, background): “● For those considering EBRT, higher dose radiation may decrease the risk of PSA recurrence;(27,35) ● When compared with WW, RP may lower the risk of cancer recurrence and improve survival.(10)”